tirzepatide august 22 2025 ESC 2025: study supports use of semaglutide, in cardiometabolic HFpEF patients Compounded Semaglutide & Tirzepatide 2025:

When looking at the benefits of the GLPs, it seems it may be a magic anti-inflammatory, in addition to potential weight loss and diabetes improvements

Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Literature Review on Pathophysiology and Treatment

The general recommendation is for at least 150 minutes of moderate-intensity exercise (like brisk walking, cycling, or swimming) per week, along with muscle-strengthening activities on two or more days

May also struggle with mood swings and feelings of anxiety

Check your state Medicaid program for the most current information

W.PetersH.et al (2011)